NAMPT and type 2 diabetes mellitus: Chen et al [40], in a case–control study on 120 non–obese individuals, reported higher plasma levels of circulating visfatin in patients with type 2 diabetes mellitus than in non diabetic subjects after adjustment for gender, age and BMI.